Corticobasal Ganglionic Degeneration

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

This chapter focuses on the corticobasal ganglionic degeneration (CBD) and describes the clinical features suggestive of the pathological diagnosis of CBD. CBD is a relatively rare neurodegenerative disease. The clinical features associated with CBD consist of any combination of the following signs and symptoms: action and postural tremor, rarely rest tremor, bra­dykinesia, myoclonus, ideomotor apraxia, alien limb phenomena, limb dystonia, gait impairment, dysarthria, aphasia, apraxia of speech, asymmetrical parkinsonism cognitive impairment, neuropsychiatric features, and dementia. The features of CBD, regardless of whether they are predominantly motor or predominantly cognitive, tend to be strongly asymmetrical. The clinical features suggestive of CBD in the absence of pathological confirmation are referred to as “corticobasal syndrome” (CBS). The chapter also discusses the diagnostic criteria for CBD, diagnostic investigations of CBD, macroscopic and microscopic findings of CBD, and pathology and genetics of CBD.

Original languageEnglish (US)
Pages (from-to)375-396
Number of pages22
JournalBlue Books of Neurology
Volume34
Issue numberC
DOIs
StatePublished - Jan 1 2010

Fingerprint

Tremor
Ideomotor Apraxia
Apraxias
Dysarthria
Hypokinesia
Myoclonus
Dystonia
Aphasia
Parkinsonian Disorders
Rare Diseases
Gait
Neurodegenerative Diseases
Signs and Symptoms
Dementia
Extremities
Pathology
Cognitive Dysfunction

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Corticobasal Ganglionic Degeneration. / Josephs, Keith Anthony.

In: Blue Books of Neurology, Vol. 34, No. C, 01.01.2010, p. 375-396.

Research output: Contribution to journalArticle

@article{f11350a1aaeb44108b1fa02c5116fb16,
title = "Corticobasal Ganglionic Degeneration",
abstract = "This chapter focuses on the corticobasal ganglionic degeneration (CBD) and describes the clinical features suggestive of the pathological diagnosis of CBD. CBD is a relatively rare neurodegenerative disease. The clinical features associated with CBD consist of any combination of the following signs and symptoms: action and postural tremor, rarely rest tremor, bra­dykinesia, myoclonus, ideomotor apraxia, alien limb phenomena, limb dystonia, gait impairment, dysarthria, aphasia, apraxia of speech, asymmetrical parkinsonism cognitive impairment, neuropsychiatric features, and dementia. The features of CBD, regardless of whether they are predominantly motor or predominantly cognitive, tend to be strongly asymmetrical. The clinical features suggestive of CBD in the absence of pathological confirmation are referred to as “corticobasal syndrome” (CBS). The chapter also discusses the diagnostic criteria for CBD, diagnostic investigations of CBD, macroscopic and microscopic findings of CBD, and pathology and genetics of CBD.",
author = "Josephs, {Keith Anthony}",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/B978-1-4160-6641-5.00022-2",
language = "English (US)",
volume = "34",
pages = "375--396",
journal = "Blue Books of Neurology",
issn = "1877-184X",
publisher = "Elsevier Inc.",
number = "C",

}

TY - JOUR

T1 - Corticobasal Ganglionic Degeneration

AU - Josephs, Keith Anthony

PY - 2010/1/1

Y1 - 2010/1/1

N2 - This chapter focuses on the corticobasal ganglionic degeneration (CBD) and describes the clinical features suggestive of the pathological diagnosis of CBD. CBD is a relatively rare neurodegenerative disease. The clinical features associated with CBD consist of any combination of the following signs and symptoms: action and postural tremor, rarely rest tremor, bra­dykinesia, myoclonus, ideomotor apraxia, alien limb phenomena, limb dystonia, gait impairment, dysarthria, aphasia, apraxia of speech, asymmetrical parkinsonism cognitive impairment, neuropsychiatric features, and dementia. The features of CBD, regardless of whether they are predominantly motor or predominantly cognitive, tend to be strongly asymmetrical. The clinical features suggestive of CBD in the absence of pathological confirmation are referred to as “corticobasal syndrome” (CBS). The chapter also discusses the diagnostic criteria for CBD, diagnostic investigations of CBD, macroscopic and microscopic findings of CBD, and pathology and genetics of CBD.

AB - This chapter focuses on the corticobasal ganglionic degeneration (CBD) and describes the clinical features suggestive of the pathological diagnosis of CBD. CBD is a relatively rare neurodegenerative disease. The clinical features associated with CBD consist of any combination of the following signs and symptoms: action and postural tremor, rarely rest tremor, bra­dykinesia, myoclonus, ideomotor apraxia, alien limb phenomena, limb dystonia, gait impairment, dysarthria, aphasia, apraxia of speech, asymmetrical parkinsonism cognitive impairment, neuropsychiatric features, and dementia. The features of CBD, regardless of whether they are predominantly motor or predominantly cognitive, tend to be strongly asymmetrical. The clinical features suggestive of CBD in the absence of pathological confirmation are referred to as “corticobasal syndrome” (CBS). The chapter also discusses the diagnostic criteria for CBD, diagnostic investigations of CBD, macroscopic and microscopic findings of CBD, and pathology and genetics of CBD.

UR - http://www.scopus.com/inward/record.url?scp=85023020751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85023020751&partnerID=8YFLogxK

U2 - 10.1016/B978-1-4160-6641-5.00022-2

DO - 10.1016/B978-1-4160-6641-5.00022-2

M3 - Article

AN - SCOPUS:85023020751

VL - 34

SP - 375

EP - 396

JO - Blue Books of Neurology

JF - Blue Books of Neurology

SN - 1877-184X

IS - C

ER -